Annual long term liabilities:
$334.30M-$75.90M(-18.50%)Summary
- As of today (July 1, 2025), TVTX annual total long term liabilities is $334.30 million, with the most recent change of -$75.90 million (-18.50%) on December 31, 2024.
- During the last 3 years, TVTX annual long term liabilities has fallen by -$16.14 million (-4.60%).
- TVTX annual long term liabilities is now -31.44% below its all-time high of $487.57 million, reached on December 31, 2022.
Performance
TVTX Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$333.52M-$778.00K(-0.23%)Summary
- As of today (July 1, 2025), TVTX quarterly total long term liabilities is $333.52 million, with the most recent change of -$778.00 thousand (-0.23%) on March 31, 2025.
- Over the past year, TVTX quarterly long term liabilities has dropped by -$82.73 million (-19.87%).
- TVTX quarterly long term liabilities is now -33.40% below its all-time high of $500.79 million, reached on March 31, 2022.
Performance
TVTX quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
TVTX Long term liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -18.5% | -19.9% |
| 3 y3 years | -4.6% | -33.4% |
| 5 y5 years | +16.0% | +19.4% |
TVTX Long term liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -31.4% | at low | -33.1% | at low |
| 5 y | 5-year | -31.4% | +16.0% | -33.4% | +15.0% |
| alltime | all time | -31.4% | >+9999.0% | -33.4% | >+9999.0% |
TVTX Long term liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $333.52M(-0.2%) |
| Dec 2024 | $334.30M(-18.5%) | $334.30M(-3.1%) |
| Sep 2024 | - | $344.83M(-16.9%) |
| Jun 2024 | - | $414.71M(-0.4%) |
| Mar 2024 | - | $416.25M(+1.5%) |
| Dec 2023 | $410.19M(-15.9%) | $410.19M(-0.8%) |
| Sep 2023 | - | $413.65M(-14.6%) |
| Jun 2023 | - | $484.23M(-0.9%) |
| Mar 2023 | - | $488.45M(+0.2%) |
| Dec 2022 | $487.57M(+39.1%) | $487.57M(-1.4%) |
| Sep 2022 | - | $494.51M(-0.8%) |
| Jun 2022 | - | $498.29M(-0.5%) |
| Mar 2022 | - | $500.79M(+42.9%) |
| Dec 2021 | $350.43M(+15.4%) | $350.43M(-1.2%) |
| Sep 2021 | - | $354.54M(+11.7%) |
| Jun 2021 | - | $317.49M(+0.4%) |
| Mar 2021 | - | $316.34M(+4.2%) |
| Dec 2020 | $303.57M(+5.3%) | $303.57M(-3.7%) |
| Sep 2020 | - | $315.38M(+8.7%) |
| Jun 2020 | - | $290.12M(+3.9%) |
| Mar 2020 | - | $279.22M(-3.1%) |
| Dec 2019 | $288.15M(+0.7%) | $288.15M(+3.0%) |
| Sep 2019 | - | $279.84M(-0.0%) |
| Jun 2019 | - | $279.90M(+0.7%) |
| Mar 2019 | - | $277.88M(-2.9%) |
| Dec 2018 | $286.29M | $286.29M(-3.7%) |
| Sep 2018 | - | $297.25M(+198.3%) |
| Jun 2018 | - | $99.66M(-31.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $144.79M(+2.3%) |
| Dec 2017 | $141.54M(+5.4%) | $141.54M(+7.2%) |
| Sep 2017 | - | $132.09M(+0.3%) |
| Jun 2017 | - | $131.68M(-0.9%) |
| Mar 2017 | - | $132.89M(-1.0%) |
| Dec 2016 | $134.25M(+7.1%) | $134.25M(-3.3%) |
| Sep 2016 | - | $138.83M(-0.5%) |
| Jun 2016 | - | $139.53M(+15.1%) |
| Mar 2016 | - | $121.25M(-3.2%) |
| Dec 2015 | $125.31M(+92.2%) | $125.31M(+5.6%) |
| Sep 2015 | - | $118.67M(+16.4%) |
| Jun 2015 | - | $101.98M(-29.8%) |
| Mar 2015 | - | $145.26M(+122.8%) |
| Dec 2014 | $65.18M(+1710.2%) | $65.18M(-39.1%) |
| Sep 2014 | - | $106.98M(+0.5%) |
| Jun 2014 | - | $106.48M(+565.8%) |
| Mar 2014 | - | $15.99M(+344.2%) |
| Dec 2013 | $3.60M(>+9900.0%) | $3.60M(>+9900.0%) |
| Sep 2013 | - | $0.00(0.0%) |
| Jun 2013 | - | $0.00(-100.0%) |
| Mar 2013 | - | $6.96M(>+9900.0%) |
| Dec 2012 | $0.00(0.0%) | - |
| Nov 2012 | - | $0.00(0.0%) |
| Aug 2012 | - | $0.00(0.0%) |
| May 2012 | - | $0.00(0.0%) |
| Feb 2012 | - | $0.00(0.0%) |
| Feb 2012 | $0.00(0.0%) | - |
| Nov 2011 | - | $0.00(0.0%) |
| Feb 2011 | $0.00 | $0.00 |
FAQ
- What is Travere Therapeutics annual total long term liabilities?
- What is the all time high annual long term liabilities for Travere Therapeutics?
- What is Travere Therapeutics annual long term liabilities year-on-year change?
- What is Travere Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Travere Therapeutics?
- What is Travere Therapeutics quarterly long term liabilities year-on-year change?
What is Travere Therapeutics annual total long term liabilities?
The current annual long term liabilities of TVTX is $334.30M
What is the all time high annual long term liabilities for Travere Therapeutics?
Travere Therapeutics all-time high annual total long term liabilities is $487.57M
What is Travere Therapeutics annual long term liabilities year-on-year change?
Over the past year, TVTX annual total long term liabilities has changed by -$75.90M (-18.50%)
What is Travere Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of TVTX is $333.52M
What is the all time high quarterly long term liabilities for Travere Therapeutics?
Travere Therapeutics all-time high quarterly total long term liabilities is $500.79M
What is Travere Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, TVTX quarterly total long term liabilities has changed by -$82.73M (-19.87%)